Patton Albertson Miller Group LLC Has $9.58 Million Position in McKesson Corporation (NYSE:MCK)

Patton Albertson Miller Group LLC lessened its position in McKesson Corporation (NYSE:MCK - Free Report) by 20.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,233 shares of the company's stock after selling 3,549 shares during the period. McKesson accounts for about 1.4% of Patton Albertson Miller Group LLC's portfolio, making the stock its 12th biggest holding. Patton Albertson Miller Group LLC's holdings in McKesson were worth $9,579,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of MCK. Capital A Wealth Management LLC acquired a new stake in shares of McKesson in the fourth quarter valued at about $26,000. Millstone Evans Group LLC acquired a new stake in shares of McKesson in the fourth quarter valued at about $28,000. Graney & King LLC acquired a new stake in shares of McKesson in the fourth quarter valued at about $38,000. Cornerstone Planning Group LLC increased its stake in shares of McKesson by 1,840.0% in the first quarter. Cornerstone Planning Group LLC now owns 97 shares of the company's stock valued at $67,000 after buying an additional 92 shares during the period. Finally, CoreFirst Bank & Trust acquired a new stake in shares of McKesson in the fourth quarter valued at about $67,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Price Performance

Shares of MCK stock opened at $710.87 on Friday. The stock has a market capitalization of $88.94 billion, a PE ratio of 27.52, a P/E/G ratio of 1.43 and a beta of 0.48. McKesson Corporation has a 1-year low of $464.42 and a 1-year high of $737.89. The business has a 50-day moving average of $716.12 and a 200 day moving average of $665.92.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.83 by $0.29. McKesson had a negative return on equity of 201.12% and a net margin of 0.92%. The firm had revenue of $90.82 billion during the quarter, compared to analyst estimates of $94 billion. During the same quarter in the prior year, the company earned $6.18 EPS. The business's revenue was up 18.9% compared to the same quarter last year. Analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Investors of record on Monday, June 2nd were given a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, June 2nd. This represents a $2.84 annualized dividend and a yield of 0.40%. McKesson's dividend payout ratio (DPR) is presently 10.99%.

Insider Activity at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of McKesson stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the sale, the chief accounting officer directly owned 1,972 shares of the company's stock, valued at approximately $1,432,677.72. The trade was a 21.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total value of $4,544,812.80. Following the completion of the sale, the chief financial officer directly owned 14,760 shares in the company, valued at $10,587,348. This trade represents a 30.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 52,488 shares of company stock valued at $37,242,862 in the last ninety days. Corporate insiders own 0.08% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Wall Street Zen cut McKesson from a "strong-buy" rating to a "buy" rating in a research note on Sunday, July 13th. Bank of America raised their target price on McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Evercore ISI raised their target price on McKesson from $760.00 to $800.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. Morgan Stanley reaffirmed an "overweight" rating and set a $810.00 target price (up previously from $770.00) on shares of McKesson in a research note on Wednesday. Finally, Cfra Research cut McKesson from a "moderate buy" rating to a "hold" rating in a research note on Friday, April 4th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, McKesson currently has an average rating of "Moderate Buy" and an average target price of $710.17.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.